Clinical Trial 40201

Garden Grove, CA 92845


Summary:

A phase II randomized, double-blinded, placebo-controlled parallel group trial to examine the efficacy snd safety of 4 oral does of BI 425809 once daily over a 12 week period in patients with Schizophrenia 


Qualified Participants Must:

• Men or Woman age 18-50
• Must have Schizophrenia


Qualified Participants May Receive:

Compensation for time and travel


Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.